Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-30
2005-08-30
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S121000, C544S238000, C544S281000, C544S360000, C544S363000, C544S367000, C544S364000, C544S370000, C544S373000, C544S357000, C544S374000, C514S253050, C514S253060, C514S006900, C514S253090, C514S253100, C514S254020, C514S254050, C514S254030, C514S254090, C514S254100
Reexamination Certificate
active
06936611
ABSTRACT:
Compounds of formula (I)in which R2, X, Y, Cy, L and Lp(D)nhave the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
REFERENCES:
patent: 5346907 (1994-09-01), Kerwin et al.
patent: 796866 (1997-09-01), None
patent: WO 91/00725 (1991-01-01), None
patent: WO 97/49404 (1997-12-01), None
patent: WO 98/47876 (1998-10-01), None
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/00126 (1999-01-01), None
patent: WO 99/00127 (1999-01-01), None
patent: WO 99/00128 (1999-01-01), None
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/39092 (2000-07-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 00/39118 (2000-07-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71507 (2000-11-01), None
patent: WO 00/71508 (2000-11-01), None
patent: WO 00/76970 (2000-12-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 00/77027 (2000-12-01), None
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Camp Nicholas Paul
Engel David Birenbaum
Guzzo Peter Robert
Jones Stuart Donald
Liebeschuetz John Walter
Berch Mark L
Eli Lilly and Company
Habte Kahsay
Hay Martin A.
LandOfFree
Serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3479121